Mesa Biotech Gains FDA’s Emergency Clearance for Coronavirus Test

Mesa Biotech has received an Emergency Use Authorization from the FDA or its Accula novel coronavirus diagnostic.

The rapid molecular test, which runs on the company’s hand held Accula platform, provides results in a half hour.

The San Diego company said the test will allow healthcare professionals to access laboratory quality results in their office to aid in the decision to isolate, treat or dismiss potential carriers.